Recent developments with Coherus Biosciences Inc (CHRS) have led to the company’s beta value being reach 0.90 cents.
Coherus Biosciences Inc (NASDAQ: CHRS) kicked off on Tuesday, up 0.96% from the previous trading day, before settling in for the closing price of $1.04.